These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Brain-derived neurotrophic factor serum levels in cocaine-dependent patients during early abstinence. Corominas-Roso M, Roncero C, Eiroa-Orosa FJ, Gonzalvo B, Grau-Lopez L, Ribases M, Rodriguez-Cintas L, Sánchez-Mora C, Ramos-Quiroga JA, Casas M. Eur Neuropsychopharmacol; 2013 Sep; 23(9):1078-84. PubMed ID: 23021567 [Abstract] [Full Text] [Related]
3. High levels of brain-derived neurotrophic factor are associated with treatment adherence among crack-cocaine users. Scherer JN, Schuch S, Ornell F, Sordi AO, Bristot G, Pfaffenseller B, Kapczinski F, Kessler FHP, Fumagalli F, Pechansky F, von Diemen L. Neurosci Lett; 2016 Sep 06; 630():169-175. PubMed ID: 27473943 [Abstract] [Full Text] [Related]
4. Evaluation of oxidative stress and brain-derived neurotrophic factor levels related to crack-use detoxification. Hirsch GE, Jaskulski M, Hamerski HM, Porto FG, da Silva B, Aita CAM, Kroker K, de Bem Silveira G, Silveira PCL, Santos GT, Klafke JZ, Viecili PRN. Neurosci Lett; 2018 Mar 23; 670():62-68. PubMed ID: 29374540 [Abstract] [Full Text] [Related]